Sign in

CIK 0001815974 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Anebulo Pharmaceuticals, Inc.

Sign in to watch
Ticker
ANEB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
operating
EIN
851170950
Phone
737 203 5270
Business address
C/O ANEBULO PHARMACEUTICALS, INC., 1017 RANCH ROAD 620 SOUTH, SUITE 107, LAKEWAY, TX, 78734
  1. 4 Grant or award Director acquired 1,703,577 shares (grant or award)
  2. 8-K Event Unregistered share sale
  3. 8-K Event Regulation FD disclosure · Other events
  4. 10-K Report Annual Report
  5. 8-K Event Results of operations
  6. 8-K Event Regulation FD disclosure
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 8-K Event Executive or director change
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. 8-K Event Other events
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 8-K Event Executive or director change
  19. 8-K Event Other events
  20. 4 Open-market buy Director bought 400 shares at $6.59 ($2,634)

Page 8 of 11 · 204 filings